Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.

ABSTRACT:

Background

Many studies have found that use of aspirin can lengthen survival in patients with gastrointestinal cancer. The aim of this study was to assess the survival benefit of aspirin use compared with non-aspirin use for patients with esophageal, gastric or colorectal cancer.

Methods

We searched online databases, including PubMed, the Cochrane Library, Embase and www.clinicaltrials.gov for studies that were conducted, before April 30th, 2020, to identify relevant studies. Overall survival and cancer-specific survival of esophageal, gastric and colorectal cancers among aspirin users were compared with those among non-aspirin users. Data extraction and quality evaluation were independently conducted by 2 investigators. A meta-analysis was performed to calculate the pooled

SUBMITTER: Lin JL 

PROVIDER: S-EPMC7350580 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature